Docking study of novel designed indazole derivatives against topoisomerase-II DNA gyrase enzyme for antibacterial screening

Nabeela Mareyam, Md Nematullah, Md Faheem Haider, Md Akbar, Md Azizur Rahman

PDF(2588 KB)
PDF(2588 KB)
Intelligent Pharmacy ›› 2024, Vol. 2 ›› Issue (2) : 173-182. DOI: 10.1016/j.ipha.2023.11.001

Docking study of novel designed indazole derivatives against topoisomerase-II DNA gyrase enzyme for antibacterial screening

Author information +
History +

Abstract

Aim of the study was designed for the design of novel indazole derivatives and evaluation of their docking against topoisomerase-II DNA gyrase enzyme for the antibacterial screening. Different novel substituted indazol-3-yl benzenesulfonamide derivatives were designed for the synthesis from o-chlorobenzonitrile and phenyl hydrazine reaction and further, with benzene sulphonyl chloride reaction. These were evaluated for their docking targeting topoisomerase-II DNA gyrase enzyme for the antibacterial screening. A range of binding affinity (-12.2 to -9.6 kcal/mol) was observed. Compound, 4-chloro-N-(1-phenyl-1H-indazol-3-yl)benzenesulfonamide had the highest binding affinity (-12.2 kcal/mol) which is better than the standard norfloxacin (-10.7 kcal/mol). Compounds (12a, 12c, 12e and 12g) with chloro-substitution at para position of sulfonamide had higher affinity as compared to the compounds (12b, 12d, 12f and 12h) with methyl substitution. A convenient method for the synthesis of indazole derivatives has been developed. 4-chloro-N-(1-phenyl-1H-indazol-3-yl)benzenesulfonamide had shown the best binding affinity. Further, more diverse bioactive moieties may be incorporated into indazole scaffold in the near future by future researchers and a great amount of effort may be dedicated to the exploration of medicinal approaches for their preparation and evaluation of their biological activities.

Keywords

Docking / Indazole / Pyrazole / Topoisomerase-II / DNA gyrase / Antibacterial

Cite this article

Download citation ▾
Nabeela Mareyam, Md Nematullah, Md Faheem Haider, Md Akbar, Md Azizur Rahman. Docking study of novel designed indazole derivatives against topoisomerase-II DNA gyrase enzyme for antibacterial screening. Intelligent Pharmacy, 2024, 2(2): 173‒182 https://doi.org/10.1016/j.ipha.2023.11.001

References

[1]
Zhang SG, Liang CG, Zhang WH. Recent advances in indazole-containing derivatives: synthesis and biological perspectives. Molecules. 2018;23(11):2783.
CrossRef Google scholar
[2]
Shaikh F, Rahman MA, Arif M, Verma AK, Khushtar M. Insight of synthetic methods and pharmacological activities of indazole heterocyclic derivatives. Dogo Rangsang Research Journal. 2020;10(9):144–162.
[3]
Buchel GE, Stepanenko IN, Hejl M, et al. Osmium (IV) complexes with 1H-and 2H-indazoles: tautomer identity versus spectroscopic properties and antiproliferative activity. J Inorg Biochem. 2012;113:47–54.
CrossRef Google scholar
[4]
Kumar V, Gupta K, Sirbaiya AK, Rahman MA. A review of indazole derivatives in pharmacotherapy of inflammation. Innovat International Journal of Medical & Pharmaceutical Sciences. 2021;6(5):7–12.
[5]
Gaikwad DD, Chapolikar AD, Devkate CG, et al. Synthesis of indazole motifs and their medicinal importance: an overview. Eur J Med Chem. 2014:1–30.
[6]
Atta-ur-Rahman, Malik S, Cun-heng H, Clardy J. Isolation and structure determination of nigellicine, a novel alkaloid from the seeds of nigella sativa. Tetrahedron Lett. 1985;26:2759–2762.
CrossRef Google scholar
[7]
Schmidt A. Biologically active mesomeric betaines and alkaloids, derived from 3-Hydroxypyridine, pyridin-N-oxide, nicotinic acid and picolinic acid: three types of conjugation and their consequences. Curr Org Chem. 2004;8:653.
CrossRef Google scholar
[8]
Atta-ur-Rahman, Malik S, Hasan SS, Choudhary MI, Ni CZ, Clardy J. Nigellidine -a new indazole alkaloid from the seeds of Nigella sativa. Tetrahedron Lett. 1995;36:1993–1996.
CrossRef Google scholar
[9]
Siddiqui AA, Rahman MA, Shaharyar M, Mishra R. Synthesis and anticonvulsant activity of some substituted 3, 5-diphenyl-2-pyrazoline-1-carboxamide derivatives. Chem Sci J. 2010;8(1):1–10. CSJ-.
CrossRef Google scholar
[10]
Naaz F, Srivastava R, Singh A N, et al. Molecular modeling, synthesis, antibacterial and cytotoxicity evaluation of sulfonamide derivatives of benzimidazole, indazole, benzothiazole and Thiazole. Bioorg Med Chem. 2018;26:3414–3428.
CrossRef Google scholar
[11]
Rahman MA, Siddiqui AA. Pyrazoline derivatives: a worthy insight into the recent advances and potential pharmacological activities. Int J Pharmaceut Sci Drug Res. 2010;2(3):165–175.
[12]
Shaikh F, Arif M, Khushtar M, Nematullah M, Rahman MA. Synthesis and evaluation of antibacterial activity of novel 3-methyl-1H-indazole derivative. Intelligent Pharmacy. 2023.
CrossRef Google scholar
[13]
Kumar V, Sirbaiya AK, Nematullah M, Haider MF, Rahman MA. Synthesis of 1, 3-substituted 1H-indazole derivatives and evaluation of anti-inflammatory activity in Sprague Dawley rats. Intelligent Pharmacy. 2023. https://doi.org/10.1016/j.ipha.2023.09.009.
[14]
Kumar P, Rahman MA, Wal P, Rawat P, Singh K. Design, synthesis, and anticancer evaluation of novel benzopyran 1, 3, 4-oxadiazole derivatives. Indian J Heterocycl Chem. 2020;30(3):395–402.
CrossRef Google scholar
[15]
Awasthi A, Raju MB, Rahman MA. Synthesis, in silico studies, and in vitro antiinflammatory activity of novel imidazole derivatives targeting P38 MAP kinase. ACS Omega. 2023;8(20):17788–17799.
CrossRef Google scholar
[16]
Gupta K, Sirbaiya AK, Kumar V, Rahman MA. Current perspective of synthesis of medicinally relevant benzothiazole based molecules: potential for antimicrobial and anti-inflammatory activities. Mini Rev Med Chem. 2022;22(14):1895–1935.
CrossRef Google scholar
[17]
Eram S, Mujahid M, Bagga P, Ahsan F, Rahman MA. Hepatoprotective evaluation of Galanga (Alpinia officinarum) rhizome extract against antitubercular drugs induced hepatotoxicity in rats. J Herbs, Spices, Med Plants. 2020;26(2):113–125.
CrossRef Google scholar

RIGHTS & PERMISSIONS

2023 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
AI Summary AI Mindmap
PDF(2588 KB)

Accesses

Citations

Detail

Sections
Recommended

/